1. Home
  2. GSL vs SNY Comparison

GSL vs SNY Comparison

Compare GSL & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSL

Global Ship Lease Inc New

HOLD

Current Price

$39.77

Market Cap

1.4B

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$44.31

Market Cap

104.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSL
SNY
Founded
2007
1994
Country
Greece
France
Employees
7
74846
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
104.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GSL
SNY
Price
$39.77
$44.31
Analyst Decision
Strong Buy
Buy
Analyst Count
3
5
Target Price
$44.00
$58.00
AVG Volume (30 Days)
350.1K
2.3M
Earning Date
05-18-2026
04-23-2026
Dividend Yield
6.34%
3.47%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$3.49
Revenue Next Year
N/A
$6.10
P/E Ratio
$3.49
$6.14
Revenue Growth
N/A
N/A
52 Week Low
$25.45
$42.28
52 Week High
$42.70
$52.68

Technical Indicators

Market Signals
Indicator
GSL
SNY
Relative Strength Index (RSI) 56.34 50.79
Support Level $36.97 $43.32
Resistance Level $39.91 $45.18
Average True Range (ATR) 1.08 0.57
MACD 0.16 0.14
Stochastic Oscillator 94.09 68.58

Price Performance

Historical Comparison
GSL
SNY

About GSL Global Ship Lease Inc New

Global Ship Lease Inc is a containership owner, leasing ships to container shipping companies under industry-standard, fixed-rate time charters. Its fleet comprises mid-size Post-Panamax, Cypress, and smaller containerships, which tend to serve the faster-growing non-Mainlane and intra-regional trades, collectively representing the majority of the containerized trade volume globally. The company generates revenue from chartering its vessels to liner companies.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: